Observational Study of WTC Particulate Matter and Cardiorespiratory/Vascular Dysfunction
This study is looking at how exposure to World Trade Center (WTC) particulate matter (tiny particles) might lead to heart, lung, and blood vessel problems (cardiorespiratory and vascular dysfunction). Researchers are studying 100 FDNY rescue and recovery workers who were exposed to WTC particulate matter. The goal is to understand how this exposure affects your body by measuring specific markers in your blood, such as Heme Oxygenase-1 (HO-1), Glutathione, and Total Antioxidant Capacity (TAC). These measurements will be taken over a period of up to one year to see how they change. This is an observational study, meaning researchers will collect information without giving any specific treatments.
- Study design
- This is an observational study with a planned enrollment of 100 participants. It is not a treatment study, but rather aims to understand the effects of past WTC exposure.
- What's involved
- Participants will have their levels of Heme Oxygenase-1, Glutathione, and Total Antioxidant Capacity measured over a period of up to 365 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 365 days, based on the primary endpoint timeframes.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Anna Nolan, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Levels of Heme Oxygenase-1 (HO-1)up to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of Glutathioneup to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of Total Antioxidant Capacity (TAC)up to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of Superoxide Dismutase (SOD)up to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of Macrophage inflammatory protein-2 (MIP-2)up to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of C-reactive protein (CRP)up to Day 365
All serum will be thawed once and assayed for biomarkers
- Levels of fractional exhaled nitric oxide (FeNO)up to Day 365
FeNO will be quantified using NIOX VERO®
- Score on St. George's Respiratory Questionnaire (SGRQ-C)up to Day 365
SGRQ-C is designed to assess how one's breathing is troubling a participant and how it affects one's life. The questionnaire consists of 14 questions. The total score range is 0-54; the higher the score, the worse the chest trouble.